Tobacco Industry Interference in Brazil: the Necessity of Settling Accounts

Authors

  • André Salem Szklo Divisão de Pesquisa Populacional. Instituto Nacional de Câncer José de Alencar Gomes da Silva (INCA). Rio de Janeiro (RJ), Brasil. https://orcid.org/0000-0003-1903-6188
  • Felipe Lacerda Mendes Comissão Nacional para Implementação da Convenção-Quadro no Brasil. Instituto Nacional de Câncer José de Alencar Gomes da Silva (INCA). Rio de Janeiro (RJ), Brasil. https://orcid.org/0000-0003-1071-1597
  • Tânia Maria Cavalcante Comissão Nacional para Implementação da Convenção-Quadro no Brasil. Instituto Nacional de Câncer José de Alencar Gomes da Silva (INCA). Rio de Janeiro (RJ), Brasil. https://orcid.org/0000-0001-8556-9949
  • João Ricardo Viegas Coordenador Regional das Américas para a Convenção-Quadro para o Controle do Tabaco e para o Protocolo para Eliminar o Comércio Ilícito de Produtos de Tabaco. Assessoria Internacional. Instituto Nacional de Câncer José de Alencar Gomes da Silva (INCA). Rio de Janeiro (RJ), Brasil. https://orcid.org/0000-0002-0571-2969

DOI:

https://doi.org/10.32635/2176-9745.RBC.2020v66n2.878

Keywords:

Tobacco Industry, Tobacco-Derived Products Publicity, Tobacco Use Disorder/economics, Compensation and Redress, Social Marketing

Abstract

Introduction: In Brazil, illegal actions of advertising, promotion, and sponsorship by part of the tobacco industry are increasingly identified in music events, and through social media, aimed mainly to attract young people to use cigarettes. Objective: To develop a methodology that allows the creation of a parameter of quantification of the negative impacts to the health sector of non-compliance with the law. Method: Combination of the current national information about i) the equivalence between “mean direct cost of medical care” and “deaths by diseases attributable to tobacco addiction” and ii) the equivalence between “the portion of the profit translated into marketing actions” and “deaths of smokers who contributed for the generation of this profit through purchase of cigarettes” in order to obtain the relation between “direct cost of the treatment” vs “portion of the profit translated into market actions”. The diseases selected were those that presented the biggest direct cost of treatment attributable to tobacco. Results: For every cent invested in marketing strategies by the tobacco industry, Brazil spends 1.93 times more financial resources to treat tobacco-related diseases. Conclusion: The measurement of the liability for non-compliance of the tobacco national legislation is essential to offset part of the associated costs of the treatment of patients and programs of tobacco cessation to favor the reduction of smoking prevalence in Brazil.

Downloads

Download data is not yet available.

Published

2020-05-28

How to Cite

1.
Salem Szklo A, Lacerda Mendes F, Cavalcante TM, Viegas JR. Tobacco Industry Interference in Brazil: the Necessity of Settling Accounts. Rev. Bras. Cancerol. [Internet]. 2020 May 28 [cited 2024 Dec. 23];66(2):e-11878. Available from: https://rbc.inca.gov.br/index.php/revista/article/view/878

Issue

Section

ORIGINAL ARTICLE

Most read articles by the same author(s)